Advertisement
Organisation › Details
ITM Isotope Technologies Munich SE
ITM, a privately held radiopharmaceutical biotech company founded in 2004, is dedicated to providing the most precise cancer radiotherapeutics and diagnostics to meet the needs of patients, clinicians and our partners through excellence in development, production and global supply. With patient benefit as the driving principle for all we do, ITM is advancing a broad pipeline combining its superior radioisotopes with targeting molecules to create precision oncology treatments. ITM is leveraging its leadership and nearly two decades of radioisotope expertise combined with its worldwide network to enable nuclear medicine to reach its full potential for helping patients live longer and better. *
Start | 2021-09-21 renamed | |
Group | ITM (Group) | |
Today | Isotopen Technologien München AG | |
Predecessor | Isotopen Technologien München AG | |
Industry | RADIOPHARMACEUTICAL (RPT) | |
Industry 2 | radionucleotide therapy | |
Person | Schuster, Steffen (ITM Isotopen Technologien München 201603 CEO) | |
Person 2 | Scharrer, Nicola (ITM Isotopen Technologien München 201603 Head of Marketing) | |
Region | Garching | |
Country | Germany | |
Street | 1 Lichtenbergstr. | |
City | 85748 Garching | |
Address record changed: 2022-09-18 | ||
Basic data | Employees | n. a. |
* Document for »About Section«: ITM Isotopen Technologien München AG. (5/4/21). "Press Release: ITM Establishes Subsidiary in Shanghai to Accelerate Introduction of Its Precision Oncology Portfolio in China". | ||
Record changed: 2024-02-03 |
Advertisement
More documents for ITM (Group)
- [1] ITM Isotope Technologies Munich SE. (6/5/23). "Press Release: ITM Announces €255m Investment Round, Plans to Advance Radiopharmaceutical Pipeline and to Expand Radioisotope Production Capacities". Garching....
- [2] ITM Isotope Technologies Munich SE. (3/22/22). "Press Release: ITM Receives EUR 33 Million Equity Investment to Advance Precision Oncology Pipeline of Targeted Radiopharmaceuticals". Garching....
- [3] ITM Isotope Technologies Munich SE. (2/16/22). "Press Release: ITM Receives Equity Investment of EUR 25 Million from Strategic Partner Grand Pharma". Garching & Hong Kong....
- [4] ITM Isotope Technologies Munich SE. (12/27/21). "Press Release: ITM and Grand Pharma Enter into a Commercialization Agreement for Targeted Radiopharmaceuticals in the Greater China Area". Garching & Hong Kong....
- [5] ITM Isotopen Technologien München AG. (9/13/21). "Press Release: ITM and Chengdu Gaotong Isotope Co. Ltd. Form Joint Venture to Expand Access to ITM’s Diagnostic and Therapeutic Radioisotopes in China"....
- [6] ITM Isotopen Technologien München AG. (6/10/21). "Press Release: ITM Announces EUR 25 Million (USD 30 M) Private Equity Financing to Support Advancement of Proprietary Precision Oncology Pipeline"....
- [7] ITM Isotopen Technologien München AG. (5/4/21). "Press Release: ITM Establishes Subsidiary in Shanghai to Accelerate Introduction of Its Precision Oncology Portfolio in China"....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top